Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia

References

• FouadYMChronic hepatitis C-associated thrombocytopenia: aetiology and managementTrop Gastroenterol201334586724377151
   PubMedGoogle Scholar
• MohamedSFPrevalence of thrombocytopenia in Egyptian patients with chronic hepatitis C virusJ Egypt Soc Parasitol201343361762824640862
   PubMedGoogle Scholar
• LouieKSMicallefJMPimentaJMForssenUMPrevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic reviewJ Viral Hepat201118117
   PubMed Web of Science ®Google Scholar
• WekslerBBReview article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver diseaseAliment Pharma200726Suppl. D1319
   PubMed Web of Science ®Google Scholar
• LebanoRRosatoVMasaroneMRomanoMPersicoMThe effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case reportBMC Res Notes2014715924457056
   PubMedGoogle Scholar
• AhmedOAKaisarHHHawashNEfficacy of sofosbuvir plus ribavirin with or without Peginterferon- alfa in treatment of a cohort of Egyptian patients with hepatitis C virus infectionIDDT201717295100
   Google Scholar
• Abd-ElsalamSSharaf-EldinMSolimanSElfertABadawiRAhmadYKEfficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practiceArch Virol20181631515628983675
   PubMed Web of Science ®Google Scholar
• AhmedOAKaisarHHBadawiREfficacy and safety of sofosbuvirledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infectionInfect Drug Resist20181129529829535545
   PubMed Web of Science ®Google Scholar
• AhmedOAElsebaeyMAFouadMHAOutcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infectionInfect Drug Resist20181144144529628768
   PubMed Web of Science ®Google Scholar
• AhmedOASafwatEKhalifaMOSofosbuvir plus daclatasvir in treatment of chronic hepatitis C genotype 4 infection in a cohort of Egyptian patients: an experiment the size of Egyptian villageInt J Hepatol2018201815
   Web of Science ®Google Scholar
• AkahoshiTTomikawaMKawanakaHLaparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopeniaJ Gastroenterol Hepatol201227228629021793908
   PubMed Web of Science ®Google Scholar
• BárcenaRGil-GrandeLMorenoJPartial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirinTransplantation200579111634163515940057
   PubMed Web of Science ®Google Scholar
• AminMAEl-GendyMMDawoudIEShomaANegmAMAmerTAPartial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patientsWorld J Surg20093381702171019513783
   PubMed Web of Science ®Google Scholar
• BurnessCBEltrombopag: a review of its use in the treatment of thrombocytopenia in patients with chronic hepatitis CDrugs201474161961197125331767
   PubMed Web of Science ®Google Scholar
• SharmaVUse of eltrombopag in thrombocytopenia of liver diseaseWorld J Pharmacol201434186192
   Google Scholar
• MihăilăRGCipăianRCEltrombopag in chronic hepatitis CWorld J Gastroenterol20142035125171252125253952
   PubMed Web of Science ®Google Scholar
• El-AkelWEl-SayedMHEl KassasMNational treatment programme of hepatitis C in Egypt: hepatitis C virus model of careJ Viral Hepat201724426226728145032
   PubMed Web of Science ®Google Scholar
• TchelepiHRallsPWRadinRGrantESonography of diffuse liver diseaseJ Ultrasound Med20022191023103212216750
   PubMed Web of Science ®Google Scholar
• PughRNMurray-LyonIMDawsonJLPietroniMCWilliamsRTransection of the oesophagus for bleeding oesophageal varicesBr J Surg19736086466494541913
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKlineRevolade 25mg film-coated tablets: summary of product characteristics2014 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001110/WC500089964.pdfAccessed September 15, 2014
   Google Scholar
• AfdhalNHDusheikoGMGianniniEGEltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapyGastroenterology2014146244245224126097
   PubMed Web of Science ®Google Scholar
• AfdhalNHGianniniEGTayyabGEltrombopag before procedures in patients with cirrhosis and thrombocytopeniaN Engl J Med2012367871672422913681
   PubMed Web of Science ®Google Scholar
• TillmannHLMcHutchisonJGUse of thrombopoietic agents for the thrombocytopenia of liver diseaseSemin Hematol201047326627320620438
   PubMed Web of Science ®Google Scholar
• MchutchisonJGDusheikoGShiffmanMLEltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis CN Engl J Med2007357222227223618046027
   PubMed Web of Science ®Google Scholar
• GianniniEGAfdhalNHEltrombopag in patients with chronic liver diseaseExpert Opin Pharmacother201314566967823452139
   PubMed Web of Science ®Google Scholar
• McCormickPAMurphyKMSplenomegaly, hypersplenism and coagulation abnormalities in liver diseaseBaillieres Best Pract Res Clin Gastroenterol20001461009103111139352
   PubMed Web of Science ®Google Scholar
• Peck-RadosavljevicMThrombocytopenia in liver diseaseCan J Gastroenterol200014Suppl D60D66D
   PubMedGoogle Scholar
• GianniniEGReview article: thrombocytopenia in chronic liver disease and pharmacologic treatment optionsAliment Pharmacol Ther20062381055106516611265
   PubMed Web of Science ®Google Scholar
• DrewsRECritical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patientsClin Chest Med200324460762214710693
   PubMed Web of Science ®Google Scholar
• Abd-ElsalamSHabbaEElkhalawanyWCorrelation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosisMedicine20169523e385327281094
   PubMed Web of Science ®Google Scholar
• BurnessCBEltrombopag: a review of its use in the treatment of thrombocytopenia in patients with chronic hepatitis CDrugs201474161961197125331767
   PubMed Web of Science ®Google Scholar